Duncan Smith
Question:326. Deputy Duncan Smith asked the Minister for Health the reason that some branded medicines have not been required to be reduced in price following the approval of a generic equivalent, as required by the 2021 industry agreements; and if he will make a statement on the matter. [61500/22]
View answer